Enhancement of the vasodepressor response to adenosine by nicorandil in rats: comparison with cromakalim
Keiji Saito, Kazushige Sakai
Abstract
Keiji Saito, Kazushige Sakai
Abstract
The effect of nicorandil on systemic blood pressure (SBP) and heart rate (HR) responses to adenosine was compared with that of cromakalim, an adenosine triphosphate (ATP)-sensitive K+ channel opener, in anesthetized rats. Intravenous (i.v.) adenosine in doses of 1-100 micrograms/kg elicited dose-dependent decreases in SBP, accompanied by decreases in HR. Potentiation of adenosine action by i.v. infusion of either nicorandil (10 or 30 micrograms/kg per min) or cromakalim (0.1 microgram/kg per min) occurred in all of the animals tested. After i.v. treatment with glibenclamide (20 mg/kg), an ATP-sensitive K+ channel blocker, not only adenosine action but also the enhancement of adenosine action by nicorandil and cromakalim were significantly attenuated. The present result indicates that the enhancement of the adenosine action by nicorandil and cromakalim appears to occur at least partly through ATP-sensitive K+ channel activation.
OpenAlex reports 16 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The effect of nicorandil on systemic blood pressure (SBP) and heart rate (HR) responses to adenosine was compared with that of cromakalim, an adenosine triphosphate (ATP)-sensitive K+ channel opener, in anesthetized rats. Intravenous (i.v.) adenosine in doses of 1-100 micrograms/kg elicited dose-dependent decreases in SBP, accompanied by decreases in HR. Potentiation of adenosine action by i.v. infusion of either nicorandil (10 or 30 micrograms/kg per min) or cromakalim (0.1 microgram/kg per min) occurred in all of the animals tested. After i.v. treatment with glibenclamide (20 mg/kg), an ATP-sensitive K+ channel blocker, not only adenosine action but also the enhancement of adenosine action by nicorandil and cromakalim were significantly attenuated. The present result indicates that the enhancement of the adenosine action by nicorandil and cromakalim appears to occur at least partly through ATP-sensitive K+ channel activation.
Key concepts: Nicorandil, Cromakalim, Adenosine, Glibenclamide, Internal medicine, Chemistry, Potassium channel opener, Endocrinology